14T127: Plenary III (2425–2430)

Plenary Presenter(s)

• AC

  Alessandra Ida Celia, MD (she/her/hers)

  Sapienza University of Rome
  Rome, Rome, Italy

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Audra Horomanski, MD, RhMSUS (she/her/hers)

  Stanford University
  Palo Alto, CA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Natalie McCormick, PhD, MSc (she/her/hers)

  Massachusetts General Hospital
  Boston, MA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• CM

  Chi Chiu Mok, MD, FRCP

  Tuen Mun Hospital
  Hong Kong, Hong Kong, China

  Disclosure(s): No financial relationships with ineligible companies to disclose
• SP

  Sonia Presti, BS (she/her/hers)

  Brigham and Women's Hospital
  Boston, MA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Beth Wallace, MD, MS

  Michigan Medicine, VA Ann Arbor Healthcare System
  Ann Arbor, MI, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Plenary abstract session.

Presentations:

• 11:00 AM - 11:10 AM PT

  Pregnancy Outcomes Among Patients with Vasculitis Using Administrative Claims Data
  

  Plenary Presenter: Audra Horomanski, MD, RhMSUS (she/her/hers) – Stanford University
• 11:10 AM - 11:15 AM PT

  Q&A
  
• 11:15 AM - 11:25 AM PT

  The Role of β-catenin in Synovial Lining Fibroblast Differentiation
  

  Plenary Presenter: Sonia Presti, BS (she/her/hers) – Brigham and Women's Hospital
• 11:25 AM - 11:30 AM PT

  Q&A
  
• 11:30 AM - 11:40 AM PT

  Degranulating PR3+ Myeloid Cells Characterize Proliferative Lupus Nephritis
  

  Plenary Presenter: Alessandra Ida Celia, MD (she/her/hers) – Sapienza University of Rome
• 11:40 AM - 11:45 AM PT

  Q&A
  
• 11:45 AM - 11:55 AM PT

  Unclosing Premature Mortality Gap Among Gout Patients in the US General Population, Independent of Serum Urate and Atherosclerotic Cardiovascular Risk Factors
  

  Plenary Presenter: Natalie McCormick, PhD, MSc (she/her/hers) – Massachusetts General Hospital
• 11:55 AM - 12:00 PM PT

  Q&A
  
• 12:00 PM - 12:10 PM PT

  Romosozumab versus Denosumab in High-risk Patients Treated with Glucocorticoids: Interim 12-month Results from a Pilot Randomized Controlled Trial
  

  Plenary Presenter: Chi Chiu Mok, MD, FRCP – Tuen Mun Hospital
• 12:10 PM - 12:15 PM PT

  Q&A
  
• 12:15 PM - 12:25 PM PT

  Time-Dependent Evaluation of Weighted Cumulative Glucocorticoid Exposure and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis
  

  Plenary Presenter: Beth I. Wallace, MD, MS – Michigan Medicine, VA Ann Arbor Healthcare System
• 12:25 PM - 12:30 PM PT

  Q&A